Viewing nowJanudam 25 mg (Sitagliptin Hydrochloride Dihydrate)
Sitagliptin Hydrochloride Hydrate 28.35mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.

MFDS item code 202004025 · Approved 2020.05.29 · Insurance code 694003140
Improvement of glycemic control in type 2 diabetes mellitus
This medication is used to help control blood glucose in patients with type 2 diabetes in conjunction with diet and exercise. It may be administered alone to patients who have not received medication for diabetes before. If controlling blood glucose is difficult with monotherapy, it can be used in combination with Metformin. Additionally, this medication can be added when monotherapies such as sulfonylureas, Metformin, thiazolidinediones, or insulin are insufficient for control. It enhances therapeutic effects when added to inadequate multiple drug combination therapies. Therefore, this medication is effectively used to improve blood glucose control in patients with type 2 diabetes.
This medicine is administered at 100 mg once daily, either as monotherapy or in combination therapy; the maximum daily dose is 100 mg. This medicine may be taken without regard to meals. When this medicine is coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia caused by the sulfonylurea or insulin (see Precautions for Use, 5. General Precautions). Patients with renal impairment Because dose adjustment according to renal function is necessary, assessment of renal function is recommended before treatment with this medicine and periodically thereafter. 1. No dose adjustment is necessary in patients with mild renal impairment (glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dose adjustment is necessary in patients with moderate renal impairment (glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). 3. Administer 50 mg once daily in patients with moderate renal impairment (glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2). 4. Administer 25 mg once daily in patients with severe renal impairment (glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2). This medicine may be administered without regard to the timing of dialysis.
This medication may cause severe allergic reactions; if symptoms such as skin rash or difficulty breathing occur, discontinue use immediately and consult a doctor. Acute pancreatitis is a serious potential side effect, so if symptoms such as abdominal pain or vomiting arise, seek medical attention immediately. This drug should not be used in patients with type 1 diabetes or diabetic ketoacidosis, and it should also be avoided in cases of allergy to this drug or its components. For patients with impaired renal function, dosage adjustment is necessary, and regular kidney function monitoring is important. When used with other diabetes medications or insulin that may cause hypoglycemia, be cautious of hypoglycemic symptoms, and adjustment of doses of other medications may be necessary if needed. If severe joint pain or skin blistering occurs during treatment, notify a doctor immediately, as the medication may need to be discontinued. Pregnant or breastfeeding women should avoid using this medication, and its safety and efficacy have not been established in individuals under 18 years of age. Elderly patients may have diminished renal function, so care is necessary during administration, and regular renal function tests are recommended. In case of overdose, appropriate treatment should be provided according to symptoms, and some medications may be removed by dialysis. Finally, while this medication has relatively few drug interactions, follow a doctor’s instructions when used in conjunction with certain medications.
Anaphylaxis, angioedema, Stevens-Johnson syndrome, acute pancreatitis, hypoglycemia, upper respiratory tract infection, nasopharyngitis, headache, diarrhea, abdominal pain, nausea, constipation, vomiting, severe and disability-associated arthralgia, bullous pemphigoid, myalgia, limb pain, back pain, interstitial lung disease, pruritus, thrombocytopenia, rhabdomyolysis, elevation of liver enzymes, acute renal failure, pneumonia, diabetic complications, metabolic acidosis, falls, cardiac arrest, dyspepsia, dizziness, increased serum triglycerides, gastritis, weight loss, hypertension, hypernatremia, erectile dysfunction
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air and moisture exposure, at room temperature between 1 to 30 degrees Celsius. Proper storage prolongs the drug’s effectiveness.
Pink, round, biconvex film-coated tablet
30 tablets/box (10 tablets/PTP X 3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowSitagliptin Hydrochloride Hydrate 28.35mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Korea United Pharm., Co., Ltd.

Sitagliptin Hydrochloride Hydrate 128.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 128.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 56.7mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Withus Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.